Skip to main content
. Author manuscript; available in PMC: 2012 Jun 11.
Published in final edited form as: Eur J Pharmacol. 2011 Jan 3;660(1):88–93. doi: 10.1016/j.ejphar.2010.10.109

Table 1.

Selective Orthosteric Ligands for Melanocortin Receptors.

Compound Binding Affinities 1 IC50 (nM)a Functional Assays cAMP EC50 (nM)b
MC1R MC3R MC4R MC5R MC1R MC3R MC4R MC5R
1. Tyr-Val-Nle-Gly-His-D-Nal(2′)-Arg-Trp-Asp-Arg-Phe-Gly-NH2 - 0.84 2.5 1.0 - >10,000 24(100) >10,000
2. c[(CH2)3CO-Gly-His-D-Phe-Arg-D-Trp-Cys(S)]-Asp-Arg-Phe-Gly-NH2 17 3,900 NB 1,300 NA 100 NA 1300
3. D-Phe-c[Asp-Pro-D-Phe-Arg-Trp-Lys]-NH2 - 3.7 700 1,100 - 4.9 >10,000 >1,000
4. Ac-Nle-c[Asp-Aba-D-Phe-Arg-Trp-Lys]-NH2 NB 50 NB 2,900 NA NA NA NA
5. Ac-Nle-c[Pen-Glu-His-D-Nal(2′) –Arg-Trp-Cys]-Pro-Lys-Asp-NH2 - 3.0 750 94 - NA NA NA
10. Ac-Nle-c[Asp-N-MeHis-D-Phe-N-MeArg-N-MeTrp-N-MeLys]-NH2 14 2,200 NB NB 13 NA NA NA
a

Competitive binding of ligands vs [125I]-NDP-α-MSH;

b

Adenylate cyclase assay; NB – No binding at 10−5M ligand; NA – No activity at 10−5M ligand